Advertisement Pharmaceutical Business review - Page 261 of 5221 -
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
September 13, 2024

China NMPA approves Keymed Biosciences’ Stapokibart for atopic dermatitis

The National Medical Products Administration (NMPA) of China has approved Keymed Biosciences’ new drug application granting marketing approval for Stapokibart to treat adults with moderate-to-severe atopic dermatitis.

Continue
The approval is based on results from a Phase III trial of the asset in moderate-to-severe atopic dermatitis patients. Credit: freestocks on Unsplash.
September 12, 2024

ENCell and Lucy Biotech forge alliance for mesenchymal stem cell therapy

ENCell and Lucy Biotech signed licencing agreement for EN001. Credit: E ENCell CO,. LTD./ PR Newswire.
September 11, 2024

Merck introduces single-use reactor to accelerate ADC manufacturing

The single-use reactor specifically designed to manufacture antibody drug conjugates. Credit: Merck KGaA, Darmstadt, Germany and/or its affiliates.

Contracts

August 9, 2024

Bavarian Nordic secures $156.8m US vaccine deal

The vaccine is marketed under various brand names. Credit: Mathurin NAPOLY / matnapo on Unsplash.

Boehringer Ingelheim receives EC conditional marketing approval for spesolimab

Marinus Pharmaceuticals signs collaboration agreement with Tenacia Biotechnology

Harbour BioMed, Moderna partner on immunotherapies development

Deals

Deals July 15, 2024

Merck enhances ophthalmology portfolio with EyeBio acquisition

Pharmaceutical Business Review

Biocon signs licensing and supply deal for diabetes drug in Brazil

Q32 Bio concludes merger deal with Homology Medicines

Zuellig Pharma acquires Cialis and Alimta brands from Lilly

Popular

  1. Osivax and KM Biologics sign deal for influenza vaccine in Japan
  2. Superluminal Medicines secures $120m in Series A funding round
  3. Moderna’s updated Covid-19 vaccine receives positive EMA CHMP opinion
  4. Novartis begins construction works at two RLT manufacturing facilities in US
  5. UK MHRA grants authorisation for Moderna’s updated Covid-19 vaccine

PRESS RELEASES

Gerresheimer: Innovative Silicone Oil-Free Syringe Systems for Sensitive Ophthalmic Drugs
Gerresheimer: Innovative Silicone Oil-Free Syringe Systems for Sensitive Ophthalmic Drugs
Gerresheimer Remains on Track in First Half of 2024
Gerresheimer Remains on Track in First Half of 2024
RWS Joins Meta’s Open Loop Programme to Shape Future of AI Policy
RWS Joins Meta’s Open Loop Programme to Shape Future of AI Policy
RWS’s Linguistic AI Solution Evolve Wins Prestigious 2024 AI Breakthrough Award
RWS’s Linguistic AI Solution Evolve Wins Prestigious 2024 AI Breakthrough Award
Science-Based Targets Initiative Validates RWS’ Commitment to Reducing Carbon Emissions
Science-Based Targets Initiative Validates RWS’ Commitment to Reducing Carbon Emissions

Suppliers

Whitepapers

Saving Through Partnership and Innovation
Saving Through Partnership and Innovation
Case Study: Exploring Machine Translation in a Global Pharmacovigilance Programme
Case Study: Exploring Machine Translation in a Global Pharmacovigilance Programme
Wound Care – Selecting the Right Antiseptic for Your Formulation
Wound Care – Selecting the Right Antiseptic for Your Formulation